30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

Espisurf Announces Hong Kong Distribution, U.S. Subsidiary -

Episurf Medical entered a distribution agreement with Pacific Medical Systems in Hong Kong, its first market in China, and established a U.S. subsidiary to conduct clinical studies in support of its regulatory path. Per the company's 2017 year-end report, an Investigational Device Exemption clinical trial is planned in U.S. and European centers for Episealer knee implants and will be part of a premarket approval application to FDA. (Episurf Medical AB, 4/26/18)